Article Text

Download PDFPDF
Methodological issues in corneal collagen crosslinking in post-LASIK keratectasia
  1. Henri Sueke,
  2. Balasubramanian Ramasamy,
  3. Adrian Tey,
  4. Stephen Kaye
  1. Department of Ophthalmology, Royal Liverpool University Hospital, Liverpool, UK
  1. Correspondence to Henri Sueke, Department of Ophthalmology, Royal Liverpool University Hospital, Liverpool L7 8XP, UK; hsueke{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Iatrogenic keratectasia is becoming an increasingly recognised complication of laser in situ keratomileusis (LASIK).1 Prior to the paper by Salgado et al,2 two case reports have been described in the literature using corneal collagen crosslinking (CXL) with riboflavin and ultraviolet A as a treatment option in these patients.3 4 Salgado et al describe a study examining the use of CXL in post-LASIK keratectasia. They included 22 eyes from 15 patients, observing stability of visual acuity (VA) and corneal topography at 12 months. They conclude that CXL may be of …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.